ArticleCureus2026
Iatrogenic Femoral Arteriovenous Fistula After Cardiac Ablation Presenting As Heart Failure: Successful Endovascular Repair.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Iatrogenic femoral arteriovenous fistulas (AVFs) are an uncommon but potentially significant vascular complication following catheter-based cardiac procedures, particularly those requiring femoral access. Although most AVFs remain small and hemodynamically insignificant, high-flow fistulas may result in substantial arteriovenous shunting, leading to increased cardiac preload, reduced systemic vascular resistance, and high-output heart failure. Early recognition is essential to prevent progressive hemodynamic deterioration and cardiovascular compromise. The clinical presentation of femoral AVFs is variable and may range from asymptomatic findings to overt heart failure. Imaging plays a central role in diagnosis and therapeutic planning, with computed tomography angiography enabling anatomical characterization and angiography allowing definitive diagnosis and simultaneous intervention. We report a case of symptomatic high-flow femoral AVF after cardiac ablation successfully treated with endovascular covered stent placement. Endovascular repair achieved complete exclusion of the fistulous communication with restoration of normal arterial flow and a favorable clinical outcome. During follow-up, the patient remained asymptomatic, with sustained stent patency and no evidence of recurrent arteriovenous flow. This case highlights the importance of maintaining a high index of suspicion for vascular access-related complications in patients presenting with unexplained heart failure after catheter-based procedures. It also supports the role of endovascular repair as a safe, effective, and minimally invasive treatment strategy for symptomatic high-flow femoral AVFs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.